Member Info for shandypants2

although he couldn't say much on US deal as discussions are commercial sensitive i did like it when he mentioned there has been 'plenty of interest'. This could drop in the next month or so or even weeks IMHO as it's now his focus.

Joe Bayer's interview today with proactive investors is below.

No major surprises and reiterates H2 revenue of £10.8m to meet year end target of £15.8m and £2m profit.
A few points of interests are:
1. ST going well and DTC in US and Aust gaining traction, albeit from a low base
2. New ST products will be available for peak tanning season - think this will be extension of Wonder Serum
3. Prolong - focusing on influencers and specific forums rather than general advertising (up 71% H1 2019 but from a low base)
4. Good news in that Growlase will be launched in 6 weeks so may be £100k to £200k rev this H2 (my guess - no numbers for this in FinnCap projections). Will follow Prolong model of marketing via influencers/blogs and specific forums. A 12 week trial has been completed in Oz and this was successful - guessing before and after head shots came from this etc.
5. General confidence re H2 and meeting numbers.

General point - no mention of Roots and C+L so clearly interview was essentially a marketing opportunity for IDP.
However, with current share price so low (forward 2020 PE is c6 i think) it is encouraging that IDP are endorsing H2 numbers - this is not in the share price!

https://www.proactiveinvestors.co.uk/companies/news/910453/innovadermas-first-half-revenues-advance-28-910453.html

yes looking positive for 2020. CEO seems to be making very sensible changes to the business that should reap dividends.

I particularly like that the has a lot of skin in the game too - gives me a greater level of confidence that he will deliver

possibly yes, my mistake. Apologies.

However, last week sp was below last placing price and now it is c20% higher. So for Cathal to make that statement he was preparing to do the raise at greater than current SP (at the time of interview). If this logic still applies then raise will be higher than 6p - and the 6p is pure speculation anyway as it's not yet been agreed.

He managed to get last placing at a price considerably higher than the then Venn SP so it is possible he could do same again.

No doubt we will find out in a few weeks.

Think today's rise is more to do with a growing confidence in the new combined company - plus recent interviews and support from JW and Share Prophets etc. Hopefully it will continue as still quite conservatively priced

the previous TP note with a valuation of 0.095p had a fair bit of analysis and industry comparisons and this did have an impact on the share price - not long afterwards we had the spike to 0.07 etc.

The updated TP note was lazy - merely diluting the price by the recent placing, hence it has no had no further impact.

An updated note based on updated JORC, METS and also more confidence in the resource (less inferred resources now etc) would definitely be of assistance and get EUZ back on the radar

Andi - we don't know the placing price other than it will be higher than current price.

Could easily be 7p plus - when Cathal bought company placing was at 5.6p and I think current price at that time was 3 to 4p.
He knows how to get a premium.

https://www.edisongroup.com/publication/feraccru-out-licensed-in-china/25930

Very conservative timing estimate of US deals - says next 12 months. Pretty sure this will drop in Q1, possibly in next few weeks. CEO very careful in responding to US deal in recent interviews suggests it's close IMHO

surely some of phase 3 results already priced in, FDA approval the key for me - 50p leading up to it and then blue sky afterwards, but that's 2021 so some time to wait.
I'll take 30p for now

well positioned with really efficient machines. All looks good.

Also like this response to fluctuations in Bitcoin price -

Peter Wall: There have been moments where BCH has been more profitable—but on a weekly basis, BTC has consistently outperformed both BCH and BSV. We also don’t trade our holdings in real-time, so we aren’t affected by hourly or daily fluctuations. We are very comfortable mining BTC and plan to continue doing so going forward.

all the ducks being lined up now - director purchases, TR1 of external accumulation - all points to a successful phase 3 , results of which could drop any day now.
30p by end of Jan IMHO

3.23p TP valuation is based on some quite conservative future revenues - but is c85% higher than current share price.

2021 revenue is down as £6m - if we grow from £1m to £4m this year than i think 2021 numbers will be much higher.
Also 2020 numbers are based on quite conservative % of contract wins - so these could be exceed too.

Anyway good to see that 2020 will be profitable and i think Q4 2019 could even be near breakeven as to hit £1m rev (and GB has stated this is in the bag) then Q4 rev is over £400k and admin and other costs should be in that ballpark or not much greater (especially if £400k lab costs were included in previous periods).

Hopefully a few contracts will start dropping from Far East trip and also Parity tie up (which isn't included in 2020 numbers) to get 2020 motoring.

My only concern is cash - this needs to be carefully managed to avoid another fundraise.

£5.25m placing was done only a few months ago - this could be sufficient until 2021 if revenues keep growing and costs are managed.

final top up from me - news could drop any time next week

guess £600k cash is a concern with c£1m annual loss - is another placing required

https://www.bbc.co.uk/news/business-50265414

Individual VR sales not really taking off - supports IMMO strategy of going for partnership model. People use once or twice a year etc

Current IDPO Market Cap £9m - DISH market cap £9m. DISH generated £11k revenue in last 6 months, has an unproven business model in a crowded market space and is clearly massively loss making.

Sentiment appears to be the key valuation driver rather than fundamentals.

Beggars belief IMHO

I think HVO has been purchased for it's data primarily.

If there is any value in the JVs I suspect they will be sold off

Just re-read trading update and it confirms that Tesco has made an initial order for ST. I did suggest this a few months back as Tesco already stocks Roots and it's good to see this has indeed now materialised.
Suspect it will only be in the 'big' stores (c400 ish) but will help as we approach the peak tanning season.

ST now in Boots, SD, Asda and Tesco

who knows what the market wants these days but a ballpark profit figure is usually the norm. Steady, if slightly unspectacular progress. £5m was always my low figure, so we've hit that which is encouraging, but clearly it would have been nice to have had a slightly higher figure as the DTC issues seemed to be at the back end of H1 last year so exceeding those revenues should not have been overly challenging.
However, growth of nearly 30% is still good and de-risks H2 a little so there are not many negatives. Detailed numbers will be interesting in Feb.

xxx is Vox markets (no spaces)